MIF and psoriasis: A possible explanation for these discrepancies is that Shimizus et al. determined MIF serum levels in untreated patients with active psoriasis (PASI score ≥20) in contrast with us, as 71% of our PP patients were under pharmacological treatment and with mild psoriasis (PASI = 6 ± 0.46).